NCT02140047View on ClinicalTrials.gov

Exploratory Clinical Study of MT-2301

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

September 30, 2015

Conditions
Haemophilus Influenza Type b
Interventions
BIOLOGICAL

Haemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-Low + DPT-IPV

0.25mL, subcutaneous injection

BIOLOGICAL

Haemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-High + DPT-IPV

0.5mL, subcutaneous injection

BIOLOGICAL

Haemophilus influenza type b conjugate vaccine + DPT-IPV

0.5mL, subcutaneous injection

Trial Locations (1)

Unknown

Investigational site, Fukuoka

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY